Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Elisa Martínez-Alfaro"'
Autor:
Pilar Clemente-Casares, Alberto J López-Jiménez, Itxaso Bellón-Echeverría, José Antonio Encinar, Elisa Martínez-Alfaro, Ricardo Pérez-Flores, Antonio Mas
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e18515 (2011)
Hepatitis C virus (HCV) shows a great geographical diversity reflected in the high number of circulating genotypes and subtypes. The response to HCV treatment is genotype specific, with the predominant genotype 1 showing the lowest rate of sustained
Externí odkaz:
https://doaj.org/article/19ddb3067d4245359f3c0dc954995d8e
Autor:
David Rial-Crestelo, Miguel Rodríguez-Cola, Francisco-Javier González-Gasca, Paloma Geijo-Martínez, Olga Belinchón-Moya, Elisa Martínez-Alfaro, Fernando Mateos-Rodríguez, José-Ramón Barberá, Miguel Yzusqui, Sonia Casallo, María García, Alfredo Espinosa-Gimeno, Miguel Torralba
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 1, Pp 35-43
RESUMEN Introducción: la eficacia de los agentes antivirales directos (AAD) ha quedado demostrada en ensayos clínicos tanto en mono como en coinfectados. Nuestro objetivo es analizar la efectividad y toxicidad de este tratamiento en vida real en pa
Externí odkaz:
https://doaj.org/article/5b1d77bf890e46b09a290fbea20d6d87
Autor:
Rosa Polo, Xabier García-Albéniz, Carolina Terán, Miguel Morales, David Rial-Crestelo, M. Angeles Garcinuño, Miguel García del Toro, César Hita, Juan Luis Gómez-Sirvent, Luis Buzón, Alberto Díaz de Santiago, Jose Pérez Arellano, Jesus Sanz, Pablo Bachiller, Elisa Martínez Alfaro, Vicente Díaz-Brito, Mar Masiá, Alicia Hernández-Torres, Jose M. Guerra, Jesús Santos, Piedad Arazo, Leopoldo Muñoz, Jose Ramon Arribas, Pablo Martínez de Salazar, Santiago Moreno, Miguel A. Hernán, Julia Del Amo, null Julia del Amo, Juan Berenguer, Esteban Martínez, Miguel Hernán, Xabier García de Albéniz
Publikováno v:
Clinical Microbiology and Infection. 29:85-93
To assess the effect of hydroxychloroquine (HCQ) and Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis on COVID-19 risk. EPICOS is a double-blind, placebo-controlled randomized trial conducted in Spain, Bolivia, and Ve
Autor:
Julián Solís García del Pozo, Juan Carlos Segura Luque, Fernando Mateos Rodríguez, José Javier Blanch Sancho, Elisa Martínez Alfaro, Laura García Aragonés
Publikováno v:
Postgraduate Medical Journal. 98:48-56
Several studies have documented the synergy between vancomycin/daptomycin and various beta-lactams, and clinical studies have studied this combination therapy in humans. We review the published literature on this topic to know the utility of the comb
Autor:
Miguel Yzusqui, David Rial-Crestelo, Elisa Martínez-Alfaro, José Ramón Barberá, Constanza Muñoz Hornero, Sonia Casallo, Miguel Torralba, María I. García, María Antonia Sepúlveda, Paloma Geijo-Martínez, Grupo de Estudio de Castilla la Manche de enfermedades Infecciosas, Francisco Javier González-Gasca, Alfredo Espinosa-Gimeno
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:279-287
Background Here, we assess the efficacy and safety of direct antiviral agents (DAAs) in a real-world cohort of co-infected individuals, and evaluate the consistency between clinical practice and guideline recommendations. Methods Multicenter, prospec
Autor:
Fernando Mateos Rodríguez, Marta Pareja León, Elisa Martínez-Alfaro, José Javier Blanch Sancho, Juan Carlos Segura Luque, Sergio Guillén-Martínez, Julián Solís García del Pozo
Publikováno v:
SN Comprehensive Clinical Medicine. 2:2965-2968
Osteoarticular tuberculosis comprises 1–3% of tuberculosis (TB) patients. In 50% of cases of osteoarticular TB affects the spine. Other joints, such as the ankle, hip, and knee, are less affected. The diagnosis may be delayed for months due to an i
Autor:
Elisa Martínez-Alfaro, Paloma Geijo-Martínez, Constanza Muñoz Hornero, María Antonia Sepúlveda, Francisco Javier González-Gasca, Sonia Casallo, Alfredo Espinosa-Gimeno, Miguel Torralba, María I. García, José Ramón Barberá, Miguel Yzusqui, David Rial-Crestelo
Publikováno v:
AIDS. 34:427-432
OBJECTIVE To evaluate the progression of liver stiffness after treatment with direct antiviral agents (DAAs), to identify predictive factors of fibrosis regression and to analyze the changes of scores AST-to-platelet ratio index (APRI) and Fibrosis-4
Autor:
Julián Solís García del Pozo, Marta Guzmán Pérez, Fernando Mateos Rodríguez, José Javier Blanch Sancho, Elisa Martínez Alfaro, Juan Carlos Segura Luque
Publikováno v:
Pathogens
Pathogens; Volume 10; Issue 9; Pages: 1125
Pathogens, Vol 10, Iss 1125, p 1125 (2021)
Pathogens; Volume 10; Issue 9; Pages: 1125
Pathogens, Vol 10, Iss 1125, p 1125 (2021)
Background: Leptospirosis is a worldwide zoonotic infection, and its management needs to be refined. This study aims to discern which antibiotic would be the best option to treat leptospirosis disease and analyze the efficacy of chemoprophylaxis regi
Autor:
Julián Solís García del Pozo, Consuelo Martínez Antolinos, Elisa Martínez Alfaro, Adriana Canosa Fernandez, Massimiliano Guillermo Trinidad Pereira
Publikováno v:
European Journal of Case Reports in Internal Medicine (2021)
Eur J Case Rep Intern Med
Eur J Case Rep Intern Med
We present the case of an HIV-positive patient admitted because of costal pain secondary to neoplasia. During investigations, a colonoscopy showed non-specific ulcerations. Histological examination resulted in a diagnosis of intestinal spirochetosis.
Autor:
Ahmed A. Quadeer, José A. Campillo, Marta Cerezo Moreno, Enrique Bernal, Angeles de la Concha Muñoz, Elisa Martínez-alfaro, María V. Martínez-Sánchez, Alfredo Minguela, Antonia Alcaraz, Matthew R. McKay, María J Alcaraz, Ana Pelaez, Lourdes Gimeno, Marta Hernández-olivo, José Miguel Sáez Gómez, Manuel Muro, Maite Herranz, Elisa García, Alfredo Cano
Publikováno v:
The Journal of Infectious Diseases
Background Etiopathogenesis of the clinical variability of the coronavirus disease 2019 (COVID-19) remains mostly unknown. In this study, we investigate the role of killer cell immunoglobulin-like receptor (KIR)/human leukocyte antigen class-I (HLA-I